PTC Therapeutics, Inc.
(NASDAQ : PTCT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.78%72.670.9%$624.49m
CELGCelgene Corporation
-0.07%127.561.1%$445.02m
AMGNAmgen Inc.
0.58%168.261.1%$420.90m
BIIBBiogen Inc.
0.50%283.191.2%$358.18m
REGNRegeneron Pharmaceuticals, Inc.
0.95%472.412.7%$324.88m
VRTXVertex Pharmaceuticals Incorporated
0.20%148.431.9%$265.14m
ALXNAlexion Pharmaceuticals, Inc.
1.46%135.351.9%$221.16m
ILMNIllumina, Inc.
0.31%189.913.5%$217.02m
SRPTSarepta Therapeutics, Inc.
0.38%36.8419.8%$138.97m
CLVSClovis Oncology, Inc.
0.79%72.5318.0%$130.22m
INCYIncyte Corporation
-0.78%120.252.6%$129.94m
KITEKite Pharma, Inc.
1.14%131.6616.1%$123.23m
TSROTESARO, Inc.
1.02%115.0214.7%$122.92m
AAgilent Technologies, Inc.
0.47%61.541.5%$119.59m
BMRNBioMarin Pharmaceutical Inc.
0.53%81.354.4%$109.16m

Company Profile

PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel medicines using its expertise in RNA biology. The company's internally discovered pipeline addresses multiple therapeutic areas, including rare disorders and oncology. It is focused on developing treatments to fundamentally change the lives of patients living with rare genetic disorders. The company was founded by Allan S. Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.